InterMune

InterMune Surges on EC Drug Approval
Barron's
Thu, 03/3/11 - 05:57 pm
InterMune
Esbriet
IPF
Europe
Top Biotech Takeout Targets in 2011
Minyanville
Fri, 02/18/11 - 03:32 pm
M&A
biotech
Biogen Idec
Human Genome
Seattle Genetics
GSK
Dendreon
Actelion
Biomarin
Exelixis
Vertex Pharmaceuticals
Celgene
Alexion
Shire
InterMune
Lexicon Pharmaceuticals
Savient
Merck KGaA
WedBush: Handful of biotechs to watch this quater
Yahoo/AP
Mon, 02/14/11 - 11:46 am
Achillion
Dynavax
InterMune
5 Drugmakers Headed Back to the Drawing Board
Motley Fool
Mon, 01/31/11 - 06:54 pm
Bydureon
Eli Lilly
Amylin
diabetes
MannKind
Afrezza
InterMune
Esbriet
IPF
Lorqess
Arena Pharmaceuticals
Vivus
Qnexa
European Market May Open its Doors to This Biotech
Yahoo/SmallCapInvestor
Thu, 01/13/11 - 01:19 pm
Europe
InterMune
InterMune to start new IPF drug trial
Bizjournals
Mon, 01/10/11 - 12:37 pm
IPF
InterMune
Esbriet
Biotech Busts And Breakthroughs In December
Forbes
Mon, 01/3/11 - 02:44 pm
biotech
InterMune
Orexigen
Exelixis
Dynavax
Sangamo BioSciences
Pain Therapeutics
Abiomed
Keryx
Geron
Clinical Data
InterMune – The Black Knight Of Biotech?
Investopedia
Tue, 12/21/10 - 10:46 am
biotech
InterMune
Genzyme
Gilead Sciences
GSK
Pfizer
Roche
Respiratory Stocks (ITMN, KV.A, RMD, NKTR, ISPH)
College Stock
Sun, 12/19/10 - 12:13 pm
ResMed
KV Pharmaceutical
InterMune
Inspire
Nektar
InterMune surges on EU lung drug recommendation
Yahoo/AP
Sat, 12/18/10 - 12:18 pm
InterMune
Esbriet
idiopathic pulmonary fibrosis
Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
Mon, 12/13/10 - 12:26 pm
MannKind
Afrezza
Alimera
pSivida
Seattle Genetics
brentuximab vedotin
Illuvien
AstraZeneca
Zictifa
Clinical Data
Vilazodone
Orexigen
Contrave
Bristol-Myers Squibb
Yervoy
Pfizer
Protalix BioTherapeutics
UPLYSO
Xiafaxan
Salix
Human Genome Sciences
Benlysta
Dendreon
Provenge
InterMune
Esbriet
Cell Therapeutics
pixantrone
Forest Labs
Daxas
MELA Sciences
MelaFind
XenoPort
GSK
Horizant
Spectrum Pharmaceuticals
Fusilev
Adventrx
Vertex Pharmaceuticals
Telaprevir
InterMune sells Hep C drug rights to Roche
Marketwatch
Wed, 10/6/10 - 06:54 pm
hepatitis C
InterMune
Roche
danoprevir
3 Stocks to Play Biotech
Motley Fool
Mon, 08/9/10 - 02:17 pm
Dendreon
ONYX Pharmaceuticals
Geron
Isis Pharmaceuticals
InterMune
3 Development-Stage Drugmakers Worth Watching
Motley Fool
Sun, 08/1/10 - 02:29 pm
InterMune
Medivation
Exelixis
Bristol-Myers Squibb
GSK
Roche
Seattle Genetics
Regeneron
Biotech Bounce Sends Some Winners Up 10% or More
Yahoo/Indie Reasearch
Sat, 06/12/10 - 09:14 am
Cell Therapeutics
Repros Therapeutics
Cyclacel
Amarin
Neurocrine
Idenix
InterMune
Altus
Will Adaptive Design Change The BioPharma World?
Investopedia
Fri, 05/14/10 - 08:31 am
adaptive design
Amgen
Gilead Sciences
Eli Lilly
Pfizer
InterMune
Biotech's Latest Business Mishaps
Seeking Alpha
Mon, 05/10/10 - 09:19 am
Abbott Laboratories
Bristol-Myers Squibb
GSK
InterMune
JNJ
Merck
Pfizer
Newron Pharma
Dainippon Sumitomo
When the FDA Ignores Its Advisors
Forbes
Wed, 05/5/10 - 09:09 pm
FDA
pirfenidone
InterMune
advisory panels
What Intermune's Smackdown Tells Us About the FDA
Forbes
Wed, 05/5/10 - 11:18 am
FDA
InterMune
pirfenidone
The InterMune Debacle Post-Script
TheStreet.com
Wed, 05/5/10 - 11:06 am
pirfenidone
InterMune
FDA
Pozen
Gilead Sciences

Pages